RT @endpts: Rich Heyman joins PMV Pharma, a p53 biotech, as it adds $70 million in Series D https://t.co/wgI1JkM7Dc
RT @endpts: Rich Heyman joins PMV Pharma, a p53 biotech, as it adds $70 million in Series D https://t.co/wgI1JkM7Dc
© Nextech Invest Ltd. | privacy policy